XML 51 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED EMPLOYEE COMPENSATION (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Issuance of common stock (in shares)   0
Stock options granted (in shares)   919,000
Stock options, grants in period, exercise price (in dollars per share)   $ 0.28
Stock options exercisable period   9 years 6 months
Stock-based compensation expense $ 22 $ 90
Summary of impact of outstanding stock options on consolidated results of operations [Abstract]    
Expected volatility (in hundredths)   84.00%
Expected dividend yield (in hundredths)   0.00%
Weighted average risk-free interest rate (in hundredths)   1.05%
Expected life   5 years 6 months
Forfeiture rate (in hundredths)   0.00%
Unrecognized stock compensation expense 87 87
Unrecognized stock compensation expense (in years)   1 year 6 months
Number of Shares [Roll Forward]    
Outstanding, Beginning balance (in shares)   0
Grants (in shares)   919,000
Exercised (in shares)   0
Forfeited, cancelled or expired (in shares)   0
Outstanding, Ending balance (in shares) 919,000 919,000
Exercisable (in shares) 306,333 306,333
Weighted Average Exercise Price [Roll Forward]    
Outstanding, Beginning balance (in dollars per share)   $ 0
Grants (in dollars per share)   $ 0.28
Exercised (in dollars per share)   $ 0
Forfeited, cancelled or expired (in dollars per share)   $ 0
Outstanding, Ending balance (in dollars per share) $ 0.28 $ 0.28
Exercisable (in dollars per share) $ 0.28 $ 0.28
Options, Additional Disclosures [Abstract]    
Outstanding, Remaining Contractual Life (in years)   9 years 6 months
Exercisable, Remaining Contractual Life (in years)   9 years 6 months
Outstanding, Aggregate Intrinsic Value 196 196
Exercisable, Aggregate Intrinsic Value 65 65
2013 Equity Incentive Plan [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share authorized (in shares) 2,600,000 2,600,000
Vesting period of stock awards   10 years
Stockholder ownership classification, for exercise price conditions (in hundredths) 10.00% 10.00%
10% Stockholder exercise price of any option to fair value of common shares (in hundredths) 110.00% 110.00%
Issuance of common stock (in shares)   0
Number of options exercisable (in shares) 0 0
Number of Shares [Roll Forward]    
Exercised (in shares)   0
2013 Equity Incentive Plan [Member] | Executive Officer And Board of Directors [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock options granted (in shares)   850,000
Stock options, grants in period, exercise price (in dollars per share)   $ 0.26
Grant date fair value   151
Stock options exercisable period   2 years
Stock options expiration date   Feb. 27, 2023
Number of Shares [Roll Forward]    
Grants (in shares)   850,000
Weighted Average Exercise Price [Roll Forward]    
Grants (in dollars per share)   $ 0.26
Options, Additional Disclosures [Abstract]    
Exercisable, Remaining Contractual Life (in years)   2 years
2013 Equity Incentive Plan [Member] | Certain Employees [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock options granted (in shares)   69,000
Stock options, grants in period, exercise price (in dollars per share)   $ 0.54
Grant date fair value   26
Stock options exercisable period   2 years
Stock options expiration date   Aug. 29, 2023
Number of Shares [Roll Forward]    
Grants (in shares)   69,000
Weighted Average Exercise Price [Roll Forward]    
Grants (in dollars per share)   $ 0.54
Options, Additional Disclosures [Abstract]    
Exercisable, Remaining Contractual Life (in years)   2 years
Stock Option Plans [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense   $ 0
Common stock available for future issuance (in shares) 1,681,000 1,681,000